Previous Article | Next Article ![]()
Infection and Immunity, April 2001, p. 2542-2548, Vol. 69, No. 4
Searle Research and Development, Pharmacia Company, St.
Louis, Missouri 631981; Agricultural
Genomics, Monsanto Company, St. Louis, Missouri
631672; Department of Microbiology and
Immunology, Georgetown University, Washington, D.C.
200073; Synergy Pharmaceuticals,
Sommerset, New Jersey 088734; and
Department of Medicinal Chemistry and Molecular
Pharmacology, Purdue University, West Layfayette, Indiana
47907-13335
Received 23 June 2000/Returned for modification 24 August 2000/Accepted 12 December 2000
The relative pathogenicities of three Candida
albicans strains differing in the function of
ADE2 (the gene encoding phosphoribosylaminoimidazole carboxylase) were evaluated in a murine candidiasis model. C. albicans strain CAI7 (ade2/ade2), previously
constructed by site-specific recombination, was avirulent in
immunosuppressed mice compared to the parent strain, CAF2-1, and a
heterozygous ADE2/ade2 strain obtained by
transforming CAI7 with a wild-type allele. The reduced virulence of
CAI7 was correlated with the inability to proliferate in either
synthetic medium or serum without the exogenous addition of >10 µg
of adenine/ml. The loss of virulence upon site-specific disruption of
the ade2 locus, and the restoration of wild-type virulence with the repair of just one ade2 allele,
confirmed that the ADE2 gene and de novo purine
biosynthesis were required for Candida pathogenicity.
The potential of the phosphoribosylaminoimidazole carboxylase enzyme as
a novel target for antifungal drug discovery is discussed.
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.4.2542-2548.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Virulence of a Phosphoribosylaminoimidazole Carboxylase-Deficient
Candida albicans Strain in an
Immunosuppressed Murine Model of Systemic Candidiasis
*
Corresponding author. Mailing address: Agricultural
Genomics, Monsanto Company, 800 North Lindbergh Blvd., St. Louis, MO
63167. Phone: (314) 694-8271. Fax: (314) 694-3914. E-mail:
stanton.b.dotson{at}monsanto.com.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»